Immune response to premalignancy: Insights from patients with monoclonal gammopathy Conference Paper


Author: Dhodapkar, M. V.
Title: Immune response to premalignancy: Insights from patients with monoclonal gammopathy
Conference Title: Human Immunology: Patient-Based Research
Abstract: Many patients with preneoplastic gammopathy remain clinically stable, in spite of the presence of multiple genomic abnormalities in tumor cells. Our hypothesis is that the development of clinical cancer depends not just on the genomic changes in tumor cells, but also their interactions with the host-tumor microenvironment. Recent studies have shown that the host immune system is capable of responding to preneoplastic cells. Improved understanding of this response may provide novel opportunities for early detection and immune prevention of cancer.
Keywords: inflammation; dendritic cells; antigens; lymphocytes; myeloma; multiple-myeloma; prevention; bone-marrow; killer t-cells; cross-presentation; plasma-cells; undetermined significance
Journal Title Annals of the New York Academy of Sciences
Volume: 1062
Conference Dates: 2005 May 16-18
Conference Location: New York, NY
ISBN: 0077-8923
Publisher: John Wiley & Sons  
Location: New York
Date Published: 2005-12-01
Start Page: 22
End Page: 28
Language: English
ACCESSION: WOS:000236473100003
PROVIDER: wos
PUBMED: 16461785
DOI: 10.1196/annals.1358.004
Notes: - Article; Proceedings Paper in "Human Immunology: Patient-Based Research" - Conference on Human Immunology - MAY 16-18, 2005 - New York, NY - NY Acad Sci, Dana Fdn - 2 EAST 63RD ST, NEW YORK, NY 10021 USA - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors